The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
Open accessAbstract
Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, human papillomavirus (HPV) is currently the most common pathogen responsible for female cancers. Moreover, HPV infection is associated with many other diseases, including cutaneous and anogenital warts, and genital and upper aerodigestive tract cancers. The incidence and prevalence of these pathologies vary considerably depending on factors including HPV genotype, regional conditions, the study population, and the anatomical site sampled. Recently, features of the cervicovaginal microbiota are found to be associated with the incidence of HPV-related diseases, presenting a novel approach to identify high-risk women through both blood and cervical samples. Overall, the HPV repartition data show that HPV infection and related diseases are more prevalent in developing countries. Moreover, the available (2-, 4-, and 9-valent) vaccines based on virus-like particles, despite their proven effectiveness and safety, present some limitations in terms of system development cost, transport cold chain, and oncogenic HPV variants. In addition, vaccination programs face some challenges, leading to a considerable burden of HPV infection and related diseases. Therefore, even though the new (9-valent) vaccine seems promising, next-generation vaccines as well as awareness programs associated with HPV vaccination and budget reinforcements for immunization are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Worldwide burden of cancer attributable to HPV by site, country and HPV type
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30716 · Cited by 2,322
Human papillomavirus oncoproteins: pathways to transformation
Moody, C. A., & Laimins, L. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2886 · Cited by 1,751
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010) · The Journal of Infectious Diseases · doi:10.1086/657321 · Cited by 1,641
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Worldwide burden of cervical cancer in 2008
Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr015 · Cited by 1,130
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer
Daling, J. R., Madeleine, M. M., Johnson, L. G., Schwartz, S. M., Shera, K. A., Wurscher, M. A., Carter, J. J., Porter, P. L., Galloway, D. A., & McDougall, J. K. (2004) · Cancer · doi:10.1002/cncr.20365 · Cited by 822
Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., Bosch, F. X., de Sanjosé, S., & Trottier, H. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70471-1 · Cited by 722
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
The epidemiology of genital human papillomavirus infection
Trottier, H., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.054 · Cited by 686
Pathogenesis of Human Papillomaviruses in Differentiating Epithelia
Longworth, M. S., & Laimins, L. A. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.362-372.2004 · Cited by 677
Prevalence of HPV Infection among Men: A Systematic Review of the Literature
Dunne, E. F., Nielson, C. M., Stone, K. M., Markowitz, L. E., & Giuliano, A. R. (2006) · The Journal of Infectious Diseases · doi:10.1086/507432 · Cited by 615
Chapter 6: Epidemiology and transmission dynamics of genital HPV infection
Burchell, A. N., Winer, R. L., de Sanjosé, S., & Franco, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.031 · Cited by 529
Mitra, A., MacIntyre, D. A., Marchesi, J. R., Lee, Y. S., Bennett, P. R., & Kyrgiou, M. (2016) · Microbiome · doi:10.1186/s40168-016-0203-0 · Cited by 484
Human papillomavirus genome variants
Burk, R. D., Harari, A., & Chen, Z. (2013) · Virology · doi:10.1016/j.virol.2013.07.018 · Cited by 484
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80449-9 · Cited by 471
The Vaginal Microbiota: What Have We Learned after a Decade of Molecular Characterization?
van de Wijgert, J. H. H. M., Borgdorff, H., Verhelst, R., Crucitti, T., Francis, S., Verstraelen, H., & Jespers, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105998 · Cited by 465
Graham, S. V. (2017) · Clinical Science · doi:10.1042/cs20160786 · Cited by 456
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
Systematic review of the incidence and prevalence of genital warts
Patel, H., Wagner, M., Singhal, P., & Kothari, S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-39 · Cited by 428
Norenhag, J., Du, J., Olovsson, M., Verstraelen, H., Engstrand, L., & Brusselaers, N. (2020) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15854 · Cited by 383
The known unknowns of HPV natural history
Gravitt, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57149 · Cited by 378
Richards, R. M., Lowy, D. R., Schiller, J. T., & Day, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508815103 · Cited by 375
Gillet, E., Meys, J. F., Verstraelen, H., Bosire, C., De Sutter, P., Temmerman, M., & Broeck, D. V. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-10 · Cited by 354
Arrangement of L2 within the Papillomavirus Capsid
Buck, C. B., Cheng, N., Thompson, C. D., Lowy, D. R., Steven, A. C., Schiller, J. T., & Trus, B. L. (2008) · Journal of Virology · doi:10.1128/jvi.02726-07 · Cited by 349
Patel, C., Brotherton, J. M., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.41.1700737 · Cited by 317
Brusselaers, N., Shrestha, S., van de Wijgert, J., & Verstraelen, H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.12.011 · Cited by 317
Ho, L., Chan, S. Y., Burk, R. D., Das, B. C., Fujinaga, K., Icenogle, J. P., Kahn, T., Kiviat, N., Lancaster, W., & Mavromara-Nazos, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6413-6423.1993 · Cited by 313
Cervicovaginal microbiome and natural history of HPV in a longitudinal study
Usyk, M., Zolnik, C. P., Castle, P. E., Porras, C., Herrero, R., Gradissimo, A., Gonzalez, P., Safaeian, M., Schiffman, M., Burk, R. D., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008376 · Cited by 313
The Burden of Human Papillomavirus Infections and Related Diseases in Sub-Saharan Africa
De Vuyst, H., Alemany, L., Lacey, C., Chibwesha, C. J., Sahasrabuddhe, V., Banura, C., Denny, L., & Parham, G. P. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.07.092 · Cited by 276
Kjær, S. K., Chackerian, B., van den Brule, A. J. C., Svare, E. I., Paull, G., Walbomers, J. M. M., Schiller, J. T., Bock, J. E., Sherman, M. E., Lowy, D. R., et al. (2001) · PubMed · Cited by 269
Evolution of the Papillomaviridae
Van Doorslaer, K. (2013) · Virology · doi:10.1016/j.virol.2013.05.012 · Cited by 261
Palmer, T., Wallace, L., Pollock, K. G., Cuschieri, K., Robertson, C., Kavanagh, K., & Cruickshank, M. (2019) · BMJ · doi:10.1136/bmj.l1161 · Cited by 237
Johnson, K. M., Kines, R. C., Roberts, J. N., Lowy, D. R., Schiller, J. T., & Day, P. M. (2009) · Journal of Virology · doi:10.1128/jvi.02190-08 · Cited by 231
General Acquisition of Human Papillomavirus Infections of Skin Occurs in Early Infancy
Antonsson, A., Karanfilovska, S., Lindqvist, P. G., & Hansson, B. G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2509-2514.2003 · Cited by 225
Genital human papillomavirus infection in men
Partridge, J. M., & Koutsky, L. A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70323-6 · Cited by 220
Zhao, Q., Li, S., Yu, H., Xia, N., & Modis, Y. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.002 · Cited by 197
Genital Human Papillomavirus Infection in Men
Porche, D. J. (2007) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2007.08.026 · Cited by 194
Tamarelle, J., Thiébaut, A. C. M., de Barbeyrac, B., Bébéar, C., Ravel, J., & Delarocque-Astagneau, E. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.04.019 · Cited by 191
The global health impact of vaginal dysbiosis
van de Wijgert, J. H. H. M., & Jespers, V. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.02.003 · Cited by 189
Gupta, S., Palmer, C., Bik, E. M., Cárdenas, J. P., Núñez, H., Kraal, L., Bird, S. W., Bowers, J., Smith, A. J., Walton, N. A., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00077 · Cited by 187
Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins
Bishop, B., Dasgupta, J., Klein, M., Garcea, R. L., Christensen, N. D., Zhao, R., & Chen, X. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706380200 · Cited by 183
Chan, S. Y., Ho, L., Ong, C. K., Chow, V, Drescher, B., Dürst, M., ter Meulen, J., Villa, L., Luande, J., & Mgaya, H. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2057-2066.1992 · Cited by 178
Aydin, I., Weber, S., Snijder, B., Ventayol, P. S., Kühbacher, A., Becker, M., Day, P. M., Schiller, J. T., Kann, M., Pelkmans, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004162 · Cited by 175
Human Papillomavirus Type 16 Genetic Variants: Phylogeny and Classification Based on E6 and LCR
Cornet, I., Gheit, T., Franceschi, S., Vignat, J., Burk, R. D., Sylla, B. S., Tommasino, M., Clifford, G. M., & the IARC HPV Variant Study Group (2012) · Journal of Virology · doi:10.1128/jvi.00483-12 · Cited by 171
Target Cell Cyclophilins Facilitate Human Papillomavirus Type 16 Infection
Bienkowska-Haba, M., Patel, H. D., & Sapp, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000524 · Cited by 170
Next generation prophylactic human papillomavirus vaccines
Schiller, J. T., & Müller, M. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71179-9 · Cited by 168
Prevalence and risk factors of HPV infection among women from various provinces of the world
Vinodhini, K., Shanmughapriya, S., Das, B. C., & Natarajaseenivasan, K. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2155-8 · Cited by 160
HPV16 genetic variation and the development of cervical cancer worldwide
the IARC HPV Variant Study Group, Cornet, I., Gheit, T., Iannacone, M. R., Vignat, J., Sylla, B. S., Mistro, A. D., Franceschi, S., Tommasino, M., & Clifford, G. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.508 · Cited by 150
Asiaf, A., Ahmad, S. T., Mohammad, S. O., & Zargar, M. A. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328364f273 · Cited by 149
Beachler, D. C., Jenkins, G., Safaeian, M., Kreimer, A. R., & Wentzensen, N. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv753 · Cited by 140
Cutaneous wart-associated HPV types: Prevalence and relation with patient characteristics
Bruggink, S. C., de Koning, M. N. C., Gussekloo, J., Egberts, P. F., ter Schegget, J., Feltkamp, M. C. W., Bavinck, J. N. B., Quint, W. G. V., Assendelft, W. J., & Eekhof, J. A. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.07.014 · Cited by 139
Deschuyteneer, M., Elouahabi, A., Plainchamp, D., et al. (2010) · Human Vaccines · doi:10.4161/hv.6.5.11023 · Cited by 132
Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes
Moody, C. A. (2017) · Viruses · doi:10.3390/v9090261 · Cited by 132
Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
Khodabandehlou, N., Mostafaei, S., Etemadi, A., Ghasemi, A., Payandeh, M., Hadifar, S., Norooznezhad, A. H., Kazemnejad, A., & Moghoofei, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-5286-0 · Cited by 132
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide
Chen, A. A., Gheit, T., Franceschi, S., Tommasino, M., & Clifford, G. M. (2015) · Journal of Virology · doi:10.1128/jvi.01747-15 · Cited by 130
Bhatla, N., Lal, N., Bao, Y., Ng, T. Y., & Qiao, Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.047 · Cited by 124
Baines, S., Emerson, E., Robertson, J., & Hatton, C. (2018) · BMC Public Health · doi:10.1186/s12889-018-5572-9 · Cited by 123
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
El‐Zein, M., Richardson, L., & Franco, E. L. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.020 · Cited by 118
Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus
Dasgupta, J., Bienkowska‐Haba, M., Ortega, M. E., Patel, H. D., Bodevin, S., Spillmann, D., Bishop, B., Sapp, M. J., & Chen, X. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160184 · Cited by 113
Oncogenic human papillomaviruses
McBride, A. A. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0273 · Cited by 112
Richards, K. F., Bienkowska‐Haba, M., Dasgupta, J., Chen, X. S., & Sapp, M. J. (2013) · Journal of Virology · doi:10.1128/jvi.01721-13 · Cited by 111
Zhao, Q., Modis, Y., High, K., Towne, V., Yuan, M., Wang, Y., Alexandroff, J., Brown, M. J., Carragher, B. O., Potter, C. S., et al. (2012) · Virology Journal · doi:10.1186/1743-422x-9-52 · Cited by 111
Lobão, W. M., Duarte, F. G., Burns, J. D., Santos, C. A. D. S. T., de Almeida, M. D. C. C., Reingold, A. L., & Moreira, E. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206726 · Cited by 107
Parents Who Decline HPV Vaccination: Who Later Accepts and Why?
Kornides, M. L., McRee, A., & Gilkey, M. B. (2018) · Academic Pediatrics · doi:10.1016/j.acap.2017.06.008 · Cited by 106
Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in Heterosexual Men
Nyitray, A. G., Nielson, C. M., Harris, R. B., Flores, R., Abrahamsen, M. E., Dunne, E. F., & Giuliano, A. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/588145 · Cited by 104
Sakakibara, N., Chen, D., & McBride, A. A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003321 · Cited by 101
Gilham, C., Sargent, A., Kitchener, H. C., & Peto, J. (2019) · Health Technology Assessment · doi:10.3310/hta23280 · Cited by 98
Zhang, W., Kazakov, T., Popa, A., & DiMaio, D. (2014) · mBio · doi:10.1128/mbio.01777-14 · Cited by 97
Trottier, H., Mayrand, M., Coutlée, F., Monnier, P., Laporte, L., Niyibizi, J., Carceller, A.-M., Fraser, W. D., Brassard, P., Lacroix, J., et al. (2016) · Papillomavirus Research · doi:10.1016/j.pvr.2016.07.001 · Cited by 91
Gee, J. M., Weinbaum, C. M., Sukumaran, L., & Markowitz, L. E. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1168952 · Cited by 86
de Freitas, L. B., Chen, Z., Muqui, E. F., Boldrini, N. A. T., Miranda, A. E., Spano, L. C., & Burk, R. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100746 · Cited by 85
Xia, C., Hu, S., Xu, X., Zhao, X., Qiao, Y., Broutet, N. J. N., Canfell, K., Hutubessy, R. C. W., & Zhao, F. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30162-8 · Cited by 82
Why Human Papillomavirus Acute Infections Matter
Alizon, S., Murall, C. L., & Bravo, I. G. (2017) · Viruses · doi:10.3390/v9100293 · Cited by 77
Leeman, A., Pino, M. L. D., Molijn, A. C., Rodriguez, A., Torné, A., de Koning, M. N. C., Ordï, J., van Kemenade, F. J., Jenkins, D., & Quint, W. G. V. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14682 · Cited by 75
Marcoux, D., Nadeau, K., McCuaig, C. C., Powell, J., & Oligny, L. L. (2006) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2006.00218.x · Cited by 74
Delprato, M., & Akyeampong, K. (2017) · Annals of Global Health · doi:10.1016/j.aogh.2017.10.005 · Cited by 72
Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer
LeConte, B., Szaniszlo, P., Fennewald, S. M., Lou, D. I., Qiu, S., Chen, N.-W., Lee, J. H., & Resto, V. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203403 · Cited by 69
Mikamo, H., Yamagishi, Y., Murata, S., Yokokawa, R., Han, S. R., Wakana, A., Sawata, M., & Tanaka, Y. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.069 · Cited by 62
Wang, Z. J., Wang, J., Fang, Y., Gross, D. L., Wong, M. C. S., Wong, E. L., & Lau, J. T. F. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.057 · Cited by 61
Human Papillomavirus 45 Genetic Variation and Cervical Cancer Risk Worldwide
Chen, A. A., Heideman, D. A. M., Boon, D., Gheit, T., Snijders, P. J. F., Tommasino, M., Franceschi, S., & Clifford, G. M. (2014) · Journal of Virology · doi:10.1128/jvi.03534-13 · Cited by 59
Moreira, E. D., Giuliano, A. R., Palefsky, J. M., Flores, C. A., Goldstone, S. E., Ferris, D. G., Hillman, R. J., Moi, H., Stoler, M. H., Marshall, B., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu077 · Cited by 56
Gu, Y., Wei, M., Wang, D., Li, Z., Xie, M., Pan, H., Wu, T., Zhang, J., Li, S., & Xia, N. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.084 · Cited by 55
Merckx, M., Liesbeth, W.-V. W., Arbyn, M., Meys, J., Weyers, S., Temmerman, M., & Broeck, D. V. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283592c46 · Cited by 52
Baloch, Z., Yasmeen, N., Li, Y., Zhang, W.-H., Lu, H., Wu, X., Xia, X., & Yang, S. (2017) · Medical Science Monitor · doi:10.12659/msm.903370 · Cited by 45
Tan, S. C., Ismail, M. P., Duski, D. R., Othman, N. H., & Ankathil, R. (2018) · Bioscience Reports · doi:10.1042/bsr20171268 · Cited by 45
Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer
Chen, A. A., Heideman, D. A. M., Boon, D., Chen, Z., Burk, R. D., Vuyst, H. D., Gheit, T., Snijders, P. J. F., Tommasino, M., Franceschi, S., et al. (2013) · Virology · doi:10.1016/j.virol.2013.10.033 · Cited by 44
Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines
Buchanan, T., Graybill, W. A. S., & Pierce, J. Y. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1147634 · Cited by 44
Wolday, D., Derese, M., Gebreselasie, S., Tsegaye, B., Ergete, W., Gebrehiwot, Y., Caplan, O., Wolf, D. G., & Maayan, S. L. (2018) · Infectious Agents and Cancer · doi:10.1186/s13027-018-0201-x · Cited by 44
Natural history of human papillomavirus and vaccinations in men: A literature review
Lieblong, B. J., Montgomery, B. E. E., Su, L. J., & Nakagawa, M. (2019) · Health Science Reports · doi:10.1002/hsr2.118 · Cited by 44
Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study
Zhu, C., Wang, Y., Mao, W., Zhang, H., & Ma, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023897 · Cited by 42
Vaginal microbiota and human papillomavirus: a systematic review
Mortaki, D., Gkegkes, I. D., Psomiadou, V., Blontzos, N., Prodromidou, A., Lefkopoulos, F., & Nicolaidou, E. (2019) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2019.2019.0051 · Cited by 41
Chen, W., Zhao, Y., Xie, X., Liu, J., Li, J., Zhao, C., Wang, S., Liao, X., Shou, Q., Zheng, M., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.030 · Cited by 39
El‐Zein, M., Coutlée, F., Tellier, P., Roger, M., Franco, E. L., Burchell, A. N., & HITCH Study Group (2018) · JMIR Research Protocols · doi:10.2196/11284 · Cited by 38
Liu, J., Li, H., Yang, F., Ren, Y., Xia, T., Zhao, Z., Cao, X., Wang, Z., Yin, M., & Lu, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-33511-x · Cited by 37
HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer
Zuna, R. E., Tuller, E. R., Wentzensen, N., Mathews, C. A., Allen, R. A., Shanesmith, R. P., Dunn, S. T., Gold, M. A., Wang, S., Walker, J. L., et al. (2011) · Infectious Agents and Cancer · doi:10.1186/1750-9378-6-19 · Cited by 35
Association of HIV status with infection by multiple HPV types
Camargo, M., Río‐Ospina, L. D., León, S. C. S., Sánchez, R., Pineda-Peña, A.-C., Sussmann, O., Patarroyo, M. E., & Patarroyo, M. A. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13142 · Cited by 34
Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
Ginindza, T. G., Sartorius, B. K. D., Dlamini, X., & Östensson, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177762 · Cited by 33
Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg
Latsuzbaia, A., Arbyn, M., Tapp, J., Fischer, M., Weyers, S., Pesch, P., & Mossong, J. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101593 · Cited by 33
The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts
Makiani, M. J., Shekari, M., Nejatizadeh, A., Malekzadeh, K., Baghershiroodi, M., Davudian, P., Dehghan, F., & Jamshidi, F. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2416-1 · Cited by 32
HPV Update: Vaccination, Screening, and Associated Disease
McNamara, M., Batur, P., Walsh, J. M. E., & Johnson, K. M. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3725-z · Cited by 31
Li, Z., Wang, D., Gu, Y., Song, S., He, M., Shi, J., Liu, X., Wei, S., Li, J., Yu, H. J., et al. (2017) · mBio · doi:10.1128/mbio.00787-17 · Cited by 28
Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
King, A. J., Sonsma, J. A. J., Vriend, H. J., van der Sande, M. A. B., Feltkamp, M. C. W., Boot, H. J., & Koopmans, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152782 · Cited by 27
HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif
Wu, Y. C., Chen, H., Chen, Y., Qu, L., Zhang, E., Wang, Z., Wu, Y., Yang, R., Mao, R., Lu, C., et al. (2019) · Aging · doi:10.18632/aging.101927 · Cited by 27
Mann, L. M., Llata, E., Flagg, E. W., Hong, J., Asbel, L. E., Carlos-Henderson, J., Kerani, R. P., Kohn, R., Pathela, P., Schumacher, C. M., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy684 · Cited by 26
Lee, T. S., Kothari‐Talwar, S., Singhal, P. K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025035 · Cited by 26
HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015
Brotherton, J. M. L., Winch, K. L., Chappell, G., Banks, C., Meijer, D., Ennis, S., Peterson, K. V., Webby, R., & Whop, L. J. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50221 · Cited by 26
Gurgel, A. P. A. D., Chagas, B. S., do Amaral, C. M. M., Nascimento, K. C. G., Leal, L. R. S., Neto, J. D. C. S., Muniz, M. T. C., & de Freitas, A. C. (2015) · BioMed Research International · doi:10.1155/2015/130828 · Cited by 25
Murall, C. L., Rahmoun, M., Selinger, C., Baldellou, M., Bernat, C., Bonneau, M., Boué, V., Buisson, M., Christophe, G., D’Auria, G., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025129 · Cited by 25
Senkomago, V., Backes, D. M., Hudgens, M. G., Poole, C., Agot, K. E., Moses, S., Snijders, P. J. F., Meijer, C. J. L. M., Hesselink, A. T., Schlecht, N. F., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu535 · Cited by 24
Chikandiwa, A. T., Kelly, H. A., Sawadogo, B., Ngou, J., Pisa, P. T., Gibson, L., Didelot, M.-N., Méda, N., Weiss, H. A., Segondy, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196018 · Cited by 24
Human Papillomavirus infection in men residing in Brazil, Mexico, and the USA
(2008) · Salud Pública de México · doi:10.1590/s0036-36342008000500014 · Cited by 20
Wei, F., Guo, M., Huang, S., Li, M., Cui, X., Su, Y., Wu, X., Ma, X., Zheng, Y., Huang, Y., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz168 · Cited by 18
Is Human Papilloma Virus Associated with Breast Cancer? A Review of the Molecular Evidence
Malhone, C., Longatto‐Filho, A., & Filassi, J. R. (2018) · Acta Cytologica · doi:10.1159/000487700 · Cited by 17
Ong, K. J., Checchi, M., Burns, L., Pavitt, C., Postma, M. J., & Jit, M. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053606 · Cited by 17
Anogenital warts in children: Analysis of a cohort of 34 prepubertal children
Costa‐Silva, M., Azevedo, F., & Lisboa, C. (2018) · Pediatric Dermatology · doi:10.1111/pde.13543 · Cited by 16
Wei, F., Su, Y., Yao, X., Cui, X., Bian, L., Yin, K., Yu, X., Zhuang, C., Bi, Z., Huang, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32255 · Cited by 16
Classification des papillomavirus (HPV)
Segondy, M. (2008) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(08)74274-6 · Cited by 12
Yu, Y., Guo, J., Li, D., Liu, Y., Yu, Y., & Wang, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.041 · Cited by 12
Sexual behaviour of women in rural South Africa: a descriptive study
Dubbink, J. H., van der Eem, L., McIntyre, J. A., Mbambazela, N., Jobson, G. A., Ouburg, S., Morré, S. A., Struthers, H. E., & Peters, R. P. H. (2016) · BMC Public Health · doi:10.1186/s12889-016-3207-6 · Cited by 10
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- Kombe Kombe, A. J., Li, B., Zahid, A., Mengist, H. M., Bounda, G.-A., Zhou, Y., & Jin, T.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2021-01-20
- Volume
- 8
- Pages
- 552028-552028
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W3121484186
- Cited by
- 646
- References
- 129
- FWCI
- 63.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.